Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial

BACKGROUND: Stereotactic ablative radiotherapy (SABR) has become an established treatment option for medically-inoperable early-stage (Stage I-IIA) non-small cell lung cancer (ES-NSCLC). SABR is able to obtain high rates of local control with low rates of symptomatic toxicity in this patient populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Palma, David A., Chen, Hanbo, Bahig, Houda, Gaede, Stewart, Harrow, Stephen, Laba, Joanna M., Qu, X. Melody, Rodrigues, George B., Yaremko, Brian P., Yu, Edward, Louie, Alexander V., Dhaliwal, Inderdeep, Ryerson, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905060/
https://www.ncbi.nlm.nih.gov/pubmed/31829203
http://dx.doi.org/10.1186/s12885-019-6392-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905060/
https://www.ncbi.nlm.nih.gov/pubmed/31829203
http://dx.doi.org/10.1186/s12885-019-6392-8

Ejemplares similares